{
    "clinical_study": {
        "@rank": "33290", 
        "brief_summary": {
            "textblock": "The aetiology of SAPHO syndrome seems to involve genetic, infectious and immunological\n      components. The investigators examined innate and adaptative immune responses in SAPHO\n      syndrome as compared with psoriatic arthritis and rheumatoid arthritis."
        }, 
        "brief_title": "Immune Response in the SAPHO Syndrome", 
        "completion_date": {
            "#text": "May 2008", 
            "@type": "Actual"
        }, 
        "condition": "SAPHO Syndrome", 
        "condition_browse": {
            "mesh_term": "Acquired Hyperostosis Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of SAPHO syndrome\n\n          -  Must have bone lesions\n\n        Exclusion Criteria:\n\n          -  Infliximab treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "1 Year", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "SAPHO syndrome patients"
            }
        }, 
        "enrollment": {
            "#text": "39", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688219", 
            "org_study_id": "45896566645469"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "SAPHO syndrome", 
            "Innate immunity", 
            "TNF alpha", 
            "Polymorphonuclear neutrophils", 
            "Propionibacterium acnes", 
            "Interleukin-8"
        ], 
        "lastchanged_date": "September 18, 2012", 
        "number_of_groups": "1", 
        "official_title": "Immune Mechanisms During SAPHO Syndrome and Treatment by Etarnecept", 
        "overall_official": {
            "affiliation": "Assitance Publique-Hopitaux Paris", 
            "last_name": "Gilles Hayem, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "measure": "IL-8 production by PMN", 
            "safety_issue": "No", 
            "time_frame": "24 h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688219"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "TNFalpha production by PMN", 
            "safety_issue": "No", 
            "time_frame": "24 h"
        }, 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2005", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2007"
    }
}